For research and educational purposes only. Not medical advice.
MK-0773 Reference
Educational, not medical advice reference for MK-0773: SARM; regulatory status, evidence posture, source review, and schedule notes. Also known as Non-steroi…
Reference summary
Phase 2 sarcopenia trial in postmenopausal women showed lean-mass improvements without functional-outcome benefit; the program was discontinued.
- Categories
- SARM
- Aliases
- Non-steroidal SARM, Merck Phase 2 sarcopenia investigational
- Evidence posture
- human — FDA enforcement attention. Sold only as a research chemical, not for human consumption per legal seller terms. WADA-prohibited under category S1.2 at all times. Phase 2 in sarcopenia did not advance — Merck discontinued the program. No FDA approval followed.
- Regulatory status
- No FDA-approved MK-0773 drug label. WADA prohibits SARMs under category S1.2 at all times. FDA enforcement against SARMs sellers applies. Merck advanced MK-0773 to Phase 2 sarcopenia trials, then discontinued the program.
- Content review status
- research reference